EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro

Sabina Andreu iD, Inés Ripa iD, Raquel Bello-Morales iD, José Antonio López-Guerrero iD

Viruses · 2023

DOI: 10.3390/v15040972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Sabina Andreu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Universidad Autónoma de Madrid, C/Darwin, 2 Cantoblanco, 28049 Madrid, Spain. Hauptthemen laut MEDLINE: Coronavirus 229E, Human, COVID-19, RNA Viruses. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A limited number of effective therapies are currently available to treat human coronavirus SARS-CoV-2 and other human coronaviruses, which are responsible for nearly a third of global cases of the common cold. The possibility of new emerging coronaviruses demands powerful new antiviral strategies. Lactoferrin is a well-known protein that possesses anti-inflammatory and immunomodulatory activities, and it has previously shown antiviral activity against several viruses, including SARS-CoV-2. To increase this antiviral activity, here we present bovine liposomal lactoferrin. Liposomal encapsulation of the compound was proven to increase permeability, bioavailability, and time release. In the present work, we compare the antiviral activity of free and liposomal bovine lactoferrin against HCoV229E and SARS-CoV-2 in vitro and in human primary bronchial epithelial cells, and we demonstrated that the liposomal form exerts a more potent antiviral activity than its free form at non-cytotoxic doses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronavirus 229E, HumanCOVID-19RNA VirusesHumansAntiviral AgentsSARS-CoV-2LactoferrinLiposomes

Stichwörter der Autor:innen

COVID-19SARS-CoV-2antiviralslactoferrinliposomal lactoferrin

Substanzen

Antiviral AgentsLactoferrinLiposomes

Autor:innen und Institutionen

  • Department of Molecular Biology, Universidad Autónoma de Madrid, C/Darwin, 2 Cantoblanco, 28049 Madrid, Spain.
  • Centro de Biología Molecular Severo Ochoa, Spanish National Research Council-Universidad Autónoma de Madrid (CSIC-UAM), C/Nicolás Cabrera, 1 Cantoblanco, 28049 Madrid, Spain.

ORCID-Profile: Sabina Andreu, Inés Ripa, Raquel Bello-Morales, José Antonio López-Guerrero

Zitieren

APA

Andreu, S., Ripa, I., Bello-Morales, R., & López-Guerrero, J. A. (2023). Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro. Viruses. https://doi.org/10.3390/v15040972

Vancouver

Andreu S, Ripa I, Bello-Morales R, López-Guerrero JA. Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro. Viruses. 2023. doi:10.3390/v15040972

BibTeX
@article{Andreu2023,
  author = {Andreu, Sabina and Ripa, Inés and Bello-Morales, Raquel and López-Guerrero, José Antonio},
  title = {Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15040972}
}
Kostenlos starten →